brokershub
Last seen: 4 months ago
Fundies Cheat Sheet Update: April 8, 2026
The Iran ceasefire triggered massive relief rallies, but this two-week pause isn’t peace. Oil crashed 13%, equities surged, and Fr...
Reserve Bank of New Zealand Holds OCR at 2.25%
The RBNZ held its OCR at 2.25% for a second straight meeting, but a hawkish tone from Governor Breman and a US-Iran ceasefire sent...
Watchlist: NZD/CAD – April 8, 2026
The RBNZ just turned hawkish and oil is sliding on ceasefire news — here’s the NZD/CAD confluence zone we’re watching for a potent...
Financial & Forex Market Recap: April 8, 2026
Markets surged as US-Iran ceasefire sparked massive risk rally with oil plunging over 17%, equities jumping, and dollar retreating...
We’re in our 70s with no heirs. I like donating $30,000...
“Our income — Social Security, his VA disability and three pensions — covers all expenses.”
The new high dose of Wegovy costs less than Zepbound
Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 cheaper than Eli Lilly’s competing drug.
The New York Times says it’s identified Satoshi, the in...
A report in The New York Times claims to have identified the person who goes by the pseudonym Satoshi Nakamato, the inventor of bi...
The cease-fire mirage: Here’s why stock-market bulls ma...
Goldman Sachs senior trader sees limited upside for U.S. stocks after the cease-fire between the U.S. and Iran.
The price Americans pay for medicine has gotten horribl...
We can start with laws that limit the power of pharmacy-benefit managers
Exxon and Shell reveal production hit from Iran war
Integrated oil majors Exxon Mobil and Shell each revealed how the Iran war hurt production in the first quarter.
Delta’s stock soars after a well-timed earnings report ...
Delta had better-than-expected earnings reported after the Iran cease-fire was announced.
Markets looking ‘through the noise’ of Iran war — but k...
There is still a lot of negotiating ahead, with conflicting demands from Washington and Tehran, according to the analysts